Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tyra Biosciences, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 260K | Sep 9, 2024 | Direct | ||
eFFECTOR Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 25K | Feb 19, 2024 | Direct | ||
Tyra Biosciences, Inc. | Chief Medical Officer | No securities are beneficially owned. | 0 | Sep 9, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TYRA | Tyra Biosciences, Inc. | Sep 9, 2024 | 1 | $0 | 4 | Sep 10, 2024 | Chief Medical Officer |
TYRA | Tyra Biosciences, Inc. | Sep 9, 2024 | 0 | $0 | 3 | Sep 10, 2024 | Chief Medical Officer |
EFTR | eFFECTOR Therapeutics, Inc. | Feb 19, 2024 | 1 | $0 | 4 | Feb 21, 2024 | Chief Medical Officer |
EFTR | eFFECTOR Therapeutics, Inc. | Jan 17, 2023 | 1 | $0 | 4 | Jan 19, 2023 | Chief Medical Officer |
EFTR | eFFECTOR Therapeutics, Inc. | Aug 8, 2022 | 1 | $0 | 4 | Aug 8, 2022 | Chief Medical Officer |
EFTR | eFFECTOR Therapeutics, Inc. | Aug 8, 2022 | 0 | $0 | 3 | Aug 8, 2022 | Chief Medical Officer |